tirzepatide 8/2 mg/ml Flex-Dose 2 mL Injectable 10 Lorazepam, 2mg/mL, 1mL Vial |

Microdosing may be ideal for: Individuals with mild to moderate obesity Patients sensitive to gastrointestinal side effects Those seeking gradual, sustainable weight loss People with metabolic syndrome, prediabetes, or insulin resistance Combining Tirzepatide Microdosing with Lifestyle Changes Microdosing works best when paired with: A protein-rich, nutrient-dense diet Regular strength training and cardiovascular exercise Adequate sleep (7-9 hours per night) Stress management techniques like mindfulness and breathwork Microdosing Tirzepatide offers a promising new path for patients who want to leverage the power of GLP-1 and GIP receptor agonists without overwhelming their system

Remember that effective weight management typically involves multiple approaches

Theres also a trend of greater benefit in physical functioning, body pain and general health domains with greater weight loss. Benefits with both drugs SURMOUNT-5 was a phase 3b randomized controlled open-label trial in which adults with obesity or overweight with at least one obesity-related comorbidity and at least one unsuccessful dietary attempt to lose weight were randomly assigned to once-weekly injectable semaglutide or tirzepatide for 72 weeks

Stem Cells 12 (12), 14551473

Personalized Coaching for GLP-1 Therapy Our practice offers not just prescriptions, but also a robust coaching program that works alongside GLP-1 medications

Amycretin has shown highly promising results in early stage studies for weight loss and diabetes, and it could prove even more effective than Wegovy in phase 3 clinical trials